Please wait
S-8 S-8 EX-FILING FEES 0001840229 MiNK Therapeutics, Inc. N/A Fees to be Paid Fees to be Paid 0001840229 2026-08-13 2026-08-13 0001840229 1 2026-08-13 2026-08-13 0001840229 2 2026-08-13 2026-08-13 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-8

MiNK Therapeutics, Inc.

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1 Equity Common stock, $0.00001 par value per share Other 188,249 $ 11.25 $ 2,117,801.25 0.0001381 $ 292.47
2 Equity Common stock, $0.00001 par value per share Other 47,062 $ 11.25 $ 529,447.50 0.0001381 $ 73.12

Total Offering Amounts:

$ 2,647,248.75

$ 365.59

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 365.59

Offering Note

1

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers such additional shares of MiNK Therapeutics, Inc.'s (the "Registrant's") common stock, par value $0.00001 per share ("Common Stock"), as may be issued to prevent dilution from stock splits, stock dividends and similar transactions. (2) Consists of 188,249 shares of the Registrant's Common Stock that became available for issuance on January 1, 2026 under the Registrant's 2021 Equity Incentive Plan (the "2021 EIP") resulting from the annual "evergreen" increase in the number of authorized shares reserved and available for issuance under the 2021 EIP on January 1, 2026. (3) Estimated solely for the purpose of calculating the registration fee in accordance with Rules 457(c) and 457(h), based on the average of the high and low prices of the Registrant's Common Stock as reported on the Nasdaq Capital Market on August 11, 2026. (4) The Registrant does not have any fee offsets.

2

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers such additional shares of MiNK Therapeutics, Inc.'s (the "Registrant's") common stock, par value $0.00001 per share ("Common Stock"), as may be issued to prevent dilution from stock splits, stock dividends and similar transactions. (2) Consists of 47,062 shares of the Registrant's Common Stock that became available for issuance under the Registrant's 2021 Employee Stock Purchase Plan (the "2021 ESPP") resulting from the annual "evergreen" increase in the number of authorized shares reserved and available for issuance under the 2021 ESPP on January 1, 2026. (3) Estimated solely for the purpose of calculating the registration fee in accordance with Rules 457(c) and 457(h), based on the average of the high and low prices of the Registrant's Common Stock as reported on the Nasdaq Capital Market on August 11, 2026. (4) The Registrant does not have any fee offsets.
Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rule 457(p)
Fee Offset Claims
Fee Offset Sources